PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Community Adoption / Mr Federer, page-75

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    Thanks I couldn't seem to locate this from their announcements.

    So you really can't see the significance of the median reduction where there is in some cases a complete resolution showed complete resolution of the BME and correlated dramatic pain & function scores. I noted a peer review case study that may also be of some interest
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596862/pdf/12891_2017_Article_1754.pdf.

    Let me reframe the above (ignoring pain and function) ...from the current standard of care that aggressively accelerates the disease pathology versus either placebo or iPPS, what one do you think a medical practitioner would prefer ?


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $187.1K 755.0K

Buyers (Bids)

No. Vol. Price($)
2 47906 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 13363 1
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.